Work

Treatment Timing and Early Hair Regrowth in Relation to Response to Intravenous Methylprednisolone Pulse Therapy in Alopecia Areata: A Retrospective Cohort Study

Year: 2026
Type: article
Study design: Observational Study
Abstract: We retrospectively analyzed 72 intravenous methylprednisolone (IVMP)-treated patients with moderate to severe alopecia areata to assess predictors of ≥ 50% improvement in the Severity of Alopecia Tool score at 6 months, the predictive value of 3-month hair regrowth and exploratory long-term outcomes. At 6 months, 39 patients (54.2%) responded. Shorter disease duration was associated with response (OR: per 1-unit increase in ln(months): 0.69, 95% CI: 0.51-0.95; p = 0.021), as was treatment within 6 months (OR: 4.89, 95% CI: 1.76-13.63; p = 0.002). After excluding possible self-healing acute diffuse and total alopecia cases, the adjusted association between disease duration and 6-month treatment response was no longer significant (OR: 0.74, 95% CI: 0.54-1.02; p = 0.063), whereas treatment initiation within 6 months of disease onset remained significantly associated with response. Among 46 patients with 3-month data, hair regrowth predicted the 6-month response (AUC: 0.872); a 20% threshold yielded 100% specificity and 70.8% sensitivity. Exploratory long-term outcomes were more favorable with shorter disease duration. Three-month hair regrowth may provide an early quantitative indicator of IVMP response, while the independent continuous association between disease duration and outcome warrants further investigation.
Institution: Gunma University
Language: English
Subfield: Dermatology
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $3,630
OpenAlex ID: W7227856705
FWCI:
Cites: 11
Cited by:
Related to: 10